Income-producing commercial real estate company.
Intergamma enters 2026 with a stable rental base and exceptionally low leverage, but the story has clearly shifted toward urban renewal and external expansion, so the key issue is now execution and financing quality rather than asset quality alone.
Intergamma's urban renewal profitability looks solid on paper, but the conversion into cash is slower because of 20/80 structures, interim funding needs, and meaningful reliance on shareholder loans into investees.
Intergamma’s Herzliya asset looks almost full, but the 2025 rent roll was softer than the headline suggests, while most of the compound’s value already depends on future rights and a planning-led transition rather than on current NOI alone.
The Dankner Kanlov deal may become a growth engine, but at this stage it mainly raises Intergamma's funding, governance, and execution risk.
